Skip to main content

Table 1 Patient characteristic of two groups (case)

From: Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer

 

CRT group

RT group

Statistic value

p

Gender

  

0.056

0.813

Male

24

23

Female

14

15

Age(years)

  

0.386

0.699

Range

36–70

37–70

Median

59

60.5

KPS score range

60–90

60–90

0.831

0.406

Weight loss

  

0.482

0.487

≥5%

11

10

<5%

12

13

Histological type

  

0.502

0.479

Small cell lung cancer

16

13

Non-small cell lung cancer

22

25

Brain metastasis numbers

  

0.220

0.896

1

12

11

2 ~ 3

7

6

>3

19

21

Diameter of brain metastasis

0.3 ~ 3.8

0.5 ~ 3.5

0.413

0.680

Mean diameter(cm)

1.95

1.94

0.965

0.335

Accompanied with extracranial metastasis

14

16

0.220

0.639

Brain metastasis only

24

22

 Â